Retrophin, Inc. is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. RTRX has around 3.8M shares in the U.S. ETF market. The largest ETF holder of RTRX is the SPDR S&P Biotech ETF (XBI), with approximately 1.25M shares. Investors may also find of interest that the ETF with the largest allocation to RTRX stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 1.66%. On average, U.S. ETFs allocate 0.10% of RTRX to their portfolios.
Additionally, RTRX is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RTRX as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 30.16%.